Diagnostic Yield of Exome Sequencing in Fetuses With Multisystem Malformations: Systematic Review and Meta-analysis

dc.contributor.author
Pauta, Montse
dc.contributor.author
Martínez Portilla, Raigam J.
dc.contributor.author
Borrell, Antoni
dc.date.issued
2024-10-25T16:57:16Z
dc.date.issued
2024-10-25T16:57:16Z
dc.date.issued
2022-12-01
dc.date.issued
2024-10-25T16:57:16Z
dc.identifier
0960-7692
dc.identifier
https://hdl.handle.net/2445/216063
dc.identifier
729059
dc.identifier
35041238
dc.description.abstract
Objective: To determine the diagnostic yield of exome sequencing (ES) above that of chromosomal microarray analysis (CMA) or karyotyping in fetuses with multisystem structural anomalies (at least two major anomalies in different anatomical systems). Method: This was a systematic review conducted in accordance with PRISMA guidelines. Searching PubMed, Web of Knowledge and Cochrane database, we identified studies describing ES, whole-genome and/or next-generation sequencing in fetuses with multisystem malformations. Included were observational studies involving five or more eligible fetuses. A fetus was eligible for inclusion if it had at least two major anomalies of different anatomical systems and a negative CMA or karyotyping result. Only positive variants classified as likely pathogenic or pathogenic determined to be causative of the fetal phenotype were considered. A negative CMA or karyotype result was treated as the reference standard. The diagnostic yield of the primary outcome was calculated by single-proportion analysis using random-effects modeling. A subgroup analysis was performed to compare the diagnostic yield of the solo approach (fetus alone sequenced) with that of the trio approach (fetus and both parents sequenced). Results: Seventeen articles with data on ES diagnostic yield, including 694 individuals with multisystem malformations, were identified. Overall, a pathogenic or likely pathogenic variant potentially causative of the fetal phenotype was found in 213 fetuses, giving a 33% (95% CI, 27–40%) incremental yield of ES. A stratified analysis showed similar diagnostic yields of ES using the solo approach (30%; 95% CI, 11–52%) and the trio approach (35%; 95% CI, 26–44%). Conclusions: ES applied in fetuses with multisystem structural anomalies was able to identify a potentially causative gene when CMA or karyotyping had failed to do so in an additional one-third of cases. No differences were observed between the solo and trio approaches for ES. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.
dc.format
9 p.
dc.format
application/pdf
dc.format
application/pdf
dc.language
eng
dc.publisher
John Wiley & Sons
dc.relation
Reproducció del document publicat a: https://doi.org/10.1002/uog.24862
dc.relation
Ultrasound in Obstetrics & Gynecology, 2022, vol. 77, num.12, p. 711-712
dc.relation
https://doi.org/10.1002/uog.24862
dc.rights
cc-by-nc-nd (c) Pauta, Montse et al., 2022
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)
dc.subject
Malformacions del fetus
dc.subject
Embaràs
dc.subject
Genoma humà
dc.subject
Foetus malformations
dc.subject
Pregnancy
dc.subject
Human genome
dc.title
Diagnostic Yield of Exome Sequencing in Fetuses With Multisystem Malformations: Systematic Review and Meta-analysis
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.